Cingulate (CING) Tax Provisions (2022 - 2026)
Cingulate's (CING) quarterly Tax Provisions came in at -$245082.0 in Q4 2025, down 740.65% YoY from $38255.0 in Q4 2024, and down 244.36% on a QoQ basis from $169777.0 in Q3 2025.
Cingulate (CING) Tax Provisions (2022 - 2026) Analysis & Trends
Cingulate (CING) has 4 years of Tax Provisions data on file, last reported at -$245082.0 in Q4 2025.
- Quarterly Tax Provisions fell 740.65% year-over-year to -$245082.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$231514.0 (up 76.25% YoY) and the FY2025 annual result came in at -$300532.0, up 44.49% from the prior year.
- Tax Provisions retreated to -$245082.0 in Q4 2025, from $169777.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $169777.0 in Q3 2025 to a low of -$1.4 million in Q2 2023.
- A 4-year average of -$437289.8 and a median of -$257600.0 in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 172.69% in 2025, down 740.65% in 2025.
- Tracing CING's Tax Provisions over 4 years: stood at -$257600.0 in 2022, then tumbled by 48.27% to -$381947.0 in 2023, then soared by 110.02% to $38255.0 in 2024, then tumbled by 740.65% to -$245082.0 in 2025.
- The last three Tax Provisions figures came in at -$245082.0 (Q4 2025), $169777.0 (Q3 2025), and -$194464.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Cingulate | 70.68 Mn | 70.68 Mn | - | -1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.23 Mn |
| Dec 31, 2025 | -245,082.00 |
| Sep 30, 2025 | 169,777.00 |
| Mar 31, 2025 | -194,464.00 |
| Dec 31, 2024 | 38,255.00 |
| Sep 30, 2024 | -233,562.00 |
| Jun 30, 2024 | -191,142.00 |
| Mar 31, 2024 | -588,266.00 |
| Dec 31, 2023 | -381,947.00 |
| Sep 30, 2023 | -330,642.00 |
| Jun 30, 2023 | -1.39 Mn |
| Mar 31, 2023 | -221,470.00 |
| Dec 31, 2022 | -257,600.00 |
| Sep 30, 2022 | -845,722.00 |
| Jun 30, 2022 | -848,475.00 |
| Mar 31, 2022 | -1.04 Mn |